How many institutions held BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share in Q4 2021?

181 institutional investors reported BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share for Q4 2021. Use the holders table for investor-level position and value details.

BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Q: What does CUSIP 10806X102 represent in this 13F holders report?

CUSIP 10806X102 is the security identifier for BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 10806X102

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 201,803,957
Total 13F shares: 141,976,495
Share change: +1,018,691
Total reported value: $2,367,117,577
Put/Call ratio: 59%
Price per share: $16.68
Number of holders: 181
Value change: -$117,448,257
Number of buys: 94
Number of sells: 113

Quarterly Holders Quick Answers

What is CUSIP 10806X102?
CUSIP 10806X102 identifies BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 10806X102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Kohlberg Kravis Roberts & Co. L.P.	13F	Company	15%	31,060,971	$1,455,828,000	—	30 Sep 2021	13F
VIKING GLOBAL INVESTORS LP	13F	Company	13%	26,620,991	$1,247,726,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	5%	10,141,311	$475,323,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	4.7%	9,435,412	$442,238,000	—	30 Sep 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	3.8%	7,756,928	$363,567,000	—	30 Sep 2021	13F
Aisling Capital Management LP	13F	Company	3%	6,068,125	$284,413,000	—	30 Sep 2021	13F
HHLR ADVISORS, LTD.	13F	Company	2.7%	5,362,014	$251,318,000	—	30 Sep 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	1.8%	3,728,904	$174,774,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.5%	3,083,859	$144,540,000	—	30 Sep 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.3%	2,645,441	$123,992,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.96%	1,947,085	$91,259,000	—	30 Sep 2021	13F
SC US (TTGP), LTD.	13F	Company	0.92%	1,860,364	$87,195,000	—	30 Sep 2021	13F
Cormorant Asset Management, LP	13F	Company	0.88%	1,768,909	$82,909,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	0.84%	1,688,150	$79,123,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.72%	1,454,188	$68,159,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.55%	1,115,399	$52,279,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.52%	1,047,492	$49,096,000	—	30 Sep 2021	13F
Rockefeller Capital Management L.P.	13F	Company	0.41%	836,914	$39,224,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.41%	833,232	$39,054,000	—	30 Sep 2021	13F
LORD, ABBETT & CO. LLC	13F	Company	0.39%	796,668	$37,340,000	—	30 Sep 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.37%	755,322	$35,402,000	—	30 Sep 2021	13F
Affinity Asset Advisors, LLC	13F	Company	0.32%	654,435	$30,673,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.31%	618,539	$28,991,000	—	30 Sep 2021	13F
Octagon Capital Advisors LP	13F	Company	0.28%	569,414	$26,688,000	—	30 Sep 2021	13F
Fisher Asset Management, LLC	13F	Company	0.28%	569,265	$26,681,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.28%	565,374	$26,499,000	—	30 Sep 2021	13F
Opaleye Management Inc.	13F	Company	0.25%	511,500	$23,974,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.24%	488,043	$22,875,000	—	30 Sep 2021	13F
BAMCO INC /NY/	13F	Company	0.24%	487,447	$22,847,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.24%	477,043	$22,359,000	—	30 Sep 2021	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.24%	474,976	$22,262,000	—	30 Sep 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.24%	474,820	$22,255,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.24%	474,704	$22,249,000	—	30 Sep 2021	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.23%	472,950	$22,167,000	—	30 Sep 2021	13F
PARTNERS CAPITAL INVESTMENT GROUP, LLP	13F	Company	0.23%	468,128	$21,941,000	—	30 Sep 2021	13F
CREDIT SUISSE AG/	13F	Company	0.23%	467,126	$21,895,000	—	30 Sep 2021	13F
BAILLIE GIFFORD & CO	13F	Company	0.23%	465,876	$21,835,000	—	30 Sep 2021	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.23%	460,860	$21,601,000	—	30 Sep 2021	13F
S.c.a. Candriam	13F	Individual	0.23%	455,285	$21,338,000	—	30 Sep 2021	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.22%	441,288	$20,683,000	—	30 Sep 2021	13F
TimesSquare Capital Management, LLC	13F	Company	0.2%	411,595	$19,291,000	—	30 Sep 2021	13F
LOOMIS SAYLES & CO L P	13F	Company	0.2%	408,562	$19,149,000	—	30 Sep 2021	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.19%	386,716	$18,125,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.17%	342,548	$16,055,000	—	30 Sep 2021	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0.16%	331,283	$15,527,000	—	30 Sep 2021	13F
Alberta Investment Management Corp	13F	Company	0.15%	300,000	$14,061,000	—	30 Sep 2021	13F
Nicholas Investment Partners, LP	13F	Company	0.14%	286,132	$13,411,000	—	30 Sep 2021	13F
FRANKLIN RESOURCES INC	13F	Company	0.14%	285,332	$13,374,000	—	30 Sep 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.13%	259,416	$12,159,000	—	30 Sep 2021	13F
Darwin Global Management, Ltd.	13F	Company	0.13%	253,692	$11,891,000	—	30 Sep 2021	13F

Institutional Holders of BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) as of Q4 2021

As of 31 Dec 2021, BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) was held by 181 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 141,976,495 shares. The largest 10 holders included Kohlberg Kravis Roberts & Co. L.P., VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Aisling Capital Management LP, HHLR ADVISORS, LTD., AMERICAN INTERNATIONAL GROUP, INC., STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 181 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

206

Q4 2021 holders

181

Holder diff

-25

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.